Table 4.
Peptide used as target in T cell assay | Peptide used for in vitro stimulation of T cells
|
||
---|---|---|---|
S9C | S11L | L9L | |
Patients with natural immunity to NY-ESO-1 | |||
S9C | + | + | − |
S11L | + | + | − |
L9L | − | − | − |
Vaccinated patients responding only to peptide S11L (no preexisting immunity) | |||
S9C | − | − | − |
S11L | − | + | + |
L9L | − | + | + |
Vaccinated patients responding to both peptides S9C and S11L | |||
S9C | + | + | − |
S11L | + | + | + |
L9L | − | + | + |